Your browser doesn't support javascript.
loading
Time Course and Risk Factors of New-Onset Complete Atrioventricular Block After Transcatheter Aortic Valve Implantation.
Cha, Myung-Jin; Oh, Gyu Chul; Ki, You-Jeong; Chang, Mineok; Kang, Jeehoon; Han, Jung-Kyu; Yang, Han-Mo; Park, Kyung Woo; Kang, Hyun-Jae; Koo, Bon-Kwon; Oh, Seil; Kim, Hyo-Soo.
Affiliation
  • Cha MJ; Department of Internal Medicine and Cardiovascular Center, Seoul National University Hospital.
  • Oh GC; Department of Internal Medicine and Cardiovascular Center, Seoul National University Hospital.
  • Ki YJ; Department of Internal Medicine and Cardiovascular Center, Seoul National University Hospital.
  • Chang M; Department of Internal Medicine and Cardiovascular Center, Seoul National University Hospital.
  • Kang J; Department of Internal Medicine and Cardiovascular Center, Seoul National University Hospital.
  • Han JK; Department of Internal Medicine and Cardiovascular Center, Seoul National University Hospital.
  • Yang HM; Department of Internal Medicine and Cardiovascular Center, Seoul National University Hospital.
  • Park KW; Department of Internal Medicine and Cardiovascular Center, Seoul National University Hospital.
  • Kang HJ; Department of Internal Medicine and Cardiovascular Center, Seoul National University Hospital.
  • Koo BK; Department of Internal Medicine and Cardiovascular Center, Seoul National University Hospital.
  • Oh S; Department of Internal Medicine and Cardiovascular Center, Seoul National University Hospital.
  • Kim HS; Department of Internal Medicine and Cardiovascular Center, Seoul National University Hospital.
Int Heart J ; 62(5): 988-996, 2021 Sep 30.
Article in En | MEDLINE | ID: mdl-34544968
ABSTRACT
In this study, we aimed to investigate the time course of new-onset complete atrioventricular block (CAVB) and its reversibility after transcatheter aortic valve implantation (TAVI). We analyzed 206 consecutive patients without baseline CAVB who underwent successful TAVI. The incidence of new-onset CAVB was determined to be 12.6% (26/206). Among these patients, 14 recovered from CAVB within 2 weeks (6.8%, 14/206), while the remaining 12 (5.8%, 12/206) underwent permanent pacemaker (PPM) insertion. Among the 12 patients who received the PPM, 4 were able to recover from CAVB within 4 months. Thus, only 8 among 206 patients (3.8%) showed persistent CAVB. Early-onset CAVB on the day of the procedure was the strongest predictor of PPM implantation (OR = 127). The electrocardiographic changes that occurred after TAVI were mostly recovered after 1 month. The most critical procedural factor that predicts CAVB and PPM insertion is the deep implantation (>4 mm) of a big valve (oversizing index >5.9%). In conclusion, the incidence of CAVB after TAVI was estimated to be at 12.6%. Two-thirds of these patients recovered from CAVB within 3 days, resulting in a final rate of persistent CAVB of 4%. To prevent CAVB, we have to implant an appropriate valve type with an optimal size and depth.
Subject(s)
Key words

Full text: 1 Database: MEDLINE Main subject: Aortic Valve Stenosis / Heart Valve Prosthesis Implantation / Atrioventricular Block / Transcatheter Aortic Valve Replacement Type of study: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Aged80 / Female / Humans / Male Country/Region as subject: Asia Language: En Year: 2021 Type: Article

Full text: 1 Database: MEDLINE Main subject: Aortic Valve Stenosis / Heart Valve Prosthesis Implantation / Atrioventricular Block / Transcatheter Aortic Valve Replacement Type of study: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Aged80 / Female / Humans / Male Country/Region as subject: Asia Language: En Year: 2021 Type: Article